The role of androgen deprivation therapy on the clinical course of COVID-19 infection in men with prostate cancer.
Patel V, Zhong X, Shah N, Pina Martina L, Hawley J, Lin E, Gartrell B, Adorno Febles V, Wise D, Qin Q, Mellgard G, Nauseef J, Green D, Vlachostergios P, Kwon D, Huang F, Liaw B, Tagawa S, Morris M, Oh W. The role of androgen deprivation therapy on the clinical course of COVID-19 infection in men with prostate cancer. Journal Of Clinical Oncology 2021, 39: 41-41. DOI: 10.1200/jco.2021.39.6_suppl.41.Peer-Reviewed Original ResearchSupplemental oxygen useNon-ADT cohortsRespiratory epithelial cellsProstate cancerOverall survivalOxygen usePC patientsFollow-upMedian duration of follow-upCohort of PC patientsCOVID-19 illnessEpithelial cellsPresence of active diseaseCourse of COVID-19 infectionDuration of follow-upCOVID-19 diagnosisAndrogen deprivation therapyClinical course of COVID-19 infectionFollow-up durationClinical follow-upMechanical ventilation requirementMultivariable mixed-effects logistic regressionCox proportionate hazard regression modelsUS medical centersSeverity of COVID-19 illness
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply